Fertility Drugs Won't Raise Breast Cancer Risk

WEDNESDAY, June 23, 2021 -- Women battling infertility are often given medications to help them conceive, and potential side effects are always a concern. Now, research suggests use of the drugs won't raise a woman's odds for breast...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news

Related Links:

CONCLUSION: Screening mammography in women 40-49 performed prior to initiation of ART may identify asymptomatic breast malignancy. In accordance with ACR and SBI guidelines to screen women of this age group, women of this age group should undergo screening mammography prior to ART.PMID:34507268 | DOI:10.1016/j.clinimag.2021.08.028
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Source Type: research
To prospectively investigate the association between history of infertility and risk of breast cancer.
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: Source Type: research
AbstractStudy questionDo different types of cancer affect the success of oocyte maturation in vitro compared to infertile women included in the in vitro fertilization (IVF) program?Summary answerCancer does not adversely affect oocyte maturation in vitro, with the exception of breast cancer, compared to infertile women in the in vitro fertilization program.What is known alreadyVitrification and storage of oocytes in liquid nitrogen is one of the real options for maintaining reproductive function in cancer patients. Despite careful hormonal stimulation of the ovaries, however, the proportion of oocytes is immature and lost ...
Source: Human Reproduction - Category: Reproduction Medicine Source Type: research
AbstractStudy questionIs unexplained recurrent pregnancy loss (RPL) related to long term cancer morbidity?Summary answerRecurrent unexplained pregnancy loss patients showed lower cancer morbidity. This trend was significant in the secondary aborters and in a sub-analysis for gynecological cancers.What is known alreadyThe association between infertility and cancer was studied, but has scarcely been studied in RPL; One study reported a higher incidence of breast and uterine cancers, while another found no association. Immune dysfunction is a possible cause of ‘unexplained RPL’; RPL patients have an increased numb...
Source: Human Reproduction - Category: Reproduction Medicine Source Type: research
THURSDAY, July 1, 2021 -- Women treated with ovarian stimulation drugs for infertility do not have a significantly increased risk of breast cancer, according to a systematic review and meta-analysis published in the July issue of Fertility and...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
J Clin Endocrinol Metab. 2021 Jun 22:dgab461. doi: 10.1210/clinem/dgab461. Online ahead of print.ABSTRACTCONTEXT: In a previous study we reported that anti-Müllerian hormone (AMH), a marker of ovarian reserve, is positively associated with breast cancer risk, consistent with other studies.OBJECTIVE: Assess whether risk factors for breast cancer are correlates of AMH concentration.DESIGN: Cross-sectional.PARTICIPANTS: 3831 healthy premenopausal women (aged 21-57, 87% aged 35-49).SETTING: Ten cohort studies, general population.RESULTS: Adjusting for age and cohort, we observed positive associations of AMH with age at menarche (p
Source: The Journal of Clinical Endocrinology and Metabolism - Category: Endocrinology Authors: Source Type: research
J Clin Endocrinol Metab. 2021 Jun 22:dgab461. doi: 10.1210/clinem/dgab461. Online ahead of print.ABSTRACTCONTEXT: In a previous study we reported that anti-Müllerian hormone (AMH), a marker of ovarian reserve, is positively associated with breast cancer risk, consistent with other studies.OBJECTIVE: Assess whether risk factors for breast cancer are correlates of AMH concentration.DESIGN: Cross-sectional.PARTICIPANTS: 3831 healthy premenopausal women (aged 21-57, 87% aged 35-49).SETTING: Ten cohort studies, general population.RESULTS: Adjusting for age and cohort, we observed positive associations of AMH with age at menarche (p
Source: Clinical Genitourinary Cancer - Category: Cancer & Oncology Authors: Source Type: research
There was no significant increase in the risk of breast cancer among women treated with any ovarian stimulation drug for infertility, say King's College London scientists.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
CONCLUSIONS: By facilitating referral and seeking funds and special discounts for underserved patients, supportive care programs for young women with breast cancer can play a crucial role on enhancing access to oncofertility services that would otherwise be prohibitive because of their high costs, particularly in resource-constrained settings. For these efforts to be successful and widely applied in the long term, sustained and extended governmental coverage of FP options for this young group is warranted.PMID:34153944 | DOI:10.6004/jnccn.2020.7692
Source: Journal of the National Comprehensive Cancer Network : JNCCN - Category: Cancer & Oncology Authors: Source Type: research
Breast cancer is a leading cause of death among reproductive-age women and, understandably, a source of anxiety and fear for many. Several risk factors for this often-devastating disease have been identified, including family history, obesity, socioeconomic status, and diet. Nulliparity, both elective and because of infertility, additionally confers an increased risk. Countless publications have addressed the association between exogenous hormones and breast cancer, but the link between fertility medications and cancer is unclear.
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: Tags: Reflections Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | General Medicine | Infertility | Reproduction Medicine | Women